Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Addex Therapeutics Ltd - American Depositary Shares (ADXN)
Company Research
Source: Yahoo! Finance
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 22, 2024 Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its third quarter financial results for the periods ended September 30, 2024, and provided a corporate update. “During the third quarter of 2024, Indivior selected a GABAB PAM drug candidate from our collaboration for development in substance use disorders, allowing us to select our proprietary GABAB PAM drug candidate as a potential treatment for chronic cough. While we intend to further advance this new program in-house, we will also look for partners to fund the later clinical development stages of the program,” said Tim Dyer CEO of Addex. Q3 2024 Operating Highlights: Successfully completed funded research phase of the Indivior collaboration with both Indivior and Addex each selecting GABAB
Show less
Read more
Impact Snapshot
Event Time:
ADXN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADXN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADXN alerts
High impacting Addex Therapeutics Ltd - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ADXN
News
- Addex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewswire
- Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? [Yahoo! Finance]Yahoo! Finance
- Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024GlobeNewswire
- Addex Therapeutics Ltd (VTX:ADXN) Has Found A Path To Profitability [Yahoo! Finance]Yahoo! Finance
- Exploring Three High Growth Tech Stocks In Switzerland [Yahoo! Finance]Yahoo! Finance
ADXN
Sec Filings
- 11/22/24 - Form 6-K
- 11/12/24 - Form 6-K
- 9/30/24 - Form 6-K
- ADXN's page on the SEC website